BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 810067)

  • 21. Ultrastructural pathology of skin biopsy and fibroblast enzyme studies in a case of GM2-gangliosidosis with deficient hexosaminidase A and thermolabile hexosaminidase B.
    Burck U; Harzer K; Goebel HH; Elze KL; Held KR; Carstens L
    Neuropadiatrie; 1980 May; 11(2):161-75. PubMed ID: 6255371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
    Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
    Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biochemical genetics of the hexosaminidase system in man.
    Beutler E
    Am J Hum Genet; 1979 Mar; 31(2):95-105. PubMed ID: 377957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases.
    Ou L; Przybilla MJ; Tăbăran AF; Overn P; O'Sullivan MG; Jiang X; Sidhu R; Kell PJ; Ory DS; Whitley CB
    Gene Ther; 2020 May; 27(5):226-236. PubMed ID: 31896760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of beta-D-N-acetylhexosaminidase isoenzymes in man-Chinese hamster somatic cell hybrids.
    Hoeksema HL; Reuser AJ; Hoogeveen A; Westerveld A; Braidman I; Robinson D
    Am J Hum Genet; 1977 Jan; 29(1):14-23. PubMed ID: 835571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of hexosaminidase A and B in a normal adult.
    Dreyfus JC; Poenaru L; Svennerholm L
    N Engl J Med; 1975 Jan; 292(2):61-3. PubMed ID: 1109441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In situ assessment of beta-hexosaminidase activity.
    Lacorazza HD; Jendoubi M
    Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potential of intracerebroventricular replacement of modified human β-hexosaminidase B for GM2 gangliosidosis.
    Matsuoka K; Tamura T; Tsuji D; Dohzono Y; Kitakaze K; Ohno K; Saito S; Sakuraba H; Itoh K
    Mol Ther; 2011 Jun; 19(6):1017-24. PubMed ID: 21487393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
    Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
    Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
    Tse R; Vavougios G; Hou Y; Mahuran DJ
    Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. II. Characterization and development of the regional- and cellular-specific abnormalities in the epididymis of mice with beta-hexosaminidase A deficiency.
    Adamali HI; Somani IH; Huang JQ; Gravel RA; Trasler JM; Hermo L
    J Androl; 1999; 20(6):803-24. PubMed ID: 10591619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Am J Hum Genet; 1976 Mar; 28(2):143-54. PubMed ID: 817596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of GM2 Gangliosidosis in Adult Sandhoff Mice Using an Intravenous Self-Complementary Hexosaminidase Vector.
    Osmon KJ; Thompson P; Woodley E; Karumuthil-Melethil S; Heindel C; Keimel JG; Kaemmerer WF; Gray SJ; Walia JS
    Curr Gene Ther; 2022; 22(3):262-276. PubMed ID: 34530708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
    Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
    J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sandhoff disease: impaired catabolism of sulfated glycosaminoglycans in cultured fibroblasts.
    Cantz M; O'Brien JF; Kresse H
    Birth Defects Orig Artic Ser; 1975; 11(6):261-7. PubMed ID: 127630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Hex S, the major residual beta hexosaminidase activity in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
    Ikonne JU; Rattazzi MC; Desnick RJ
    Am J Hum Genet; 1975 Sep; 27(5):639-50. PubMed ID: 240271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum beta-hexosaminidases in pregnancy.
    Lowden JA
    Clin Chim Acta; 1979 May; 93(3):409-17. PubMed ID: 445857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
    Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
    Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hexosaminidase C in brain affected by Tay-Sachs Disease.
    Minami R; Nakamura F; Oyanagi K; Nakao T
    Tohoku J Exp Med; 1981 Feb; 133(2):175-85. PubMed ID: 7268761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Cytogenet Cell Genet; 1975; 14(3-6):402-5. PubMed ID: 1192826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.